Medical Supplies, Services, Drugs Placed Under Price Control in Thailand

February 2019

In January 2019 the government of Thailand added medicine, Medical supplies and Medical services to its price control lists. The rationale behind this decision is ensuring fairness for both patients and operators of private hospitals, as pointed out by the commerce minister.

It is estimated that the impact of price controls will mostly likely be felt by the private hospitals and healthcare providers. However, on a broader level, the price controls could result in a standardization of healthcare terminologies and delivery in terms of how services are ordered.

Currently, most hospitals in Thailand, and especially those that are private, have unique software programs that are designed specifically for their internal use, making it almost impossible for electronic information-sharing across hospitals.  Price controls may pave the way for a more standardized way of recording health information to facilitate reimbursement both for healthcare providers and payers/insurance providers.

While the move towards a unified national electronic healthcare record in Thailand may not happen in the short term, the new price controls create tangible opportunities for both public and private healthcare providers to provide more value and quality to their patients through leveraging health IT technologies.

(Sources: Bangkok Post; Healthcare IT News)

Our Services

Orissa International provides consulting services to companies that want to develop a market entry strategy for Southeast Asia or implement their business expansion into the region. We have very strong domain knowledge of markets and industry sectors, and a business network of over 16,000 distributors, resellers, and system integrators, built through advising and guiding more than 5,000 companies with their market expansion into Singapore, Malaysia, Indonesia, Thailand, Vietnam and the Philippines over the last 25 years.